These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 26365781)
1. Enzymatically-responsive pro-angiogenic peptide-releasing poly(ethylene glycol) hydrogels promote vascularization in vivo. Van Hove AH; Burke K; Antonienko E; Brown E; Benoit DS J Control Release; 2015 Nov; 217():191-201. PubMed ID: 26365781 [TBL] [Abstract][Full Text] [Related]
2. Development and in vitro assessment of enzymatically-responsive poly(ethylene glycol) hydrogels for the delivery of therapeutic peptides. Van Hove AH; Beltejar MJ; Benoit DS Biomaterials; 2014 Dec; 35(36):9719-30. PubMed ID: 25178558 [TBL] [Abstract][Full Text] [Related]
3. Temporally tunable, enzymatically responsive delivery of proangiogenic peptides from poly(ethylene glycol) hydrogels. Van Hove AH; Antonienko E; Burke K; Brown E; Benoit DS Adv Healthc Mater; 2015 Sep; 4(13):2002-11. PubMed ID: 26149620 [TBL] [Abstract][Full Text] [Related]
4. In situ SVVYGLR peptide conjugation into injectable gelatin-poly(ethylene glycol)-tyramine hydrogel via enzyme-mediated reaction for enhancement of endothelial cell activity and neo-vascularization. Park KM; Lee Y; Son JY; Bae JW; Park KD Bioconjug Chem; 2012 Oct; 23(10):2042-50. PubMed ID: 22998168 [TBL] [Abstract][Full Text] [Related]
5. Poly(N-isopropylacrylamide)-based dual-crosslinking biohybrid injectable hydrogels for vascularization. Pal A; Smith CI; Palade J; Nagaraju S; Alarcon-Benedetto BA; Kilbourne J; Rawls A; Wilson-Rawls J; Vernon BL; Nikkhah M Acta Biomater; 2020 Apr; 107():138-151. PubMed ID: 32126310 [TBL] [Abstract][Full Text] [Related]
6. Improved vascularization of porous scaffolds through growth factor delivery from heparinized polyethylene glycol hydrogels. Janse van Rensburg A; Davies NH; Oosthuysen A; Chokoza C; Zilla P; Bezuidenhout D Acta Biomater; 2017 Feb; 49():89-100. PubMed ID: 27865963 [TBL] [Abstract][Full Text] [Related]
7. Injectable gelatin derivative hydrogels with sustained vascular endothelial growth factor release for induced angiogenesis. Li Z; Qu T; Ding C; Ma C; Sun H; Li S; Liu X Acta Biomater; 2015 Feb; 13():88-100. PubMed ID: 25462840 [TBL] [Abstract][Full Text] [Related]
8. Design and characterization of hydrogel nanoparticles with tunable network characteristics for sustained release of a VEGF-mimetic peptide. Young DA; Pimentel MB; Lima LD; Custodio AF; Lo WC; Chen SC; Teymour F; Papavasiliou G Biomater Sci; 2017 Sep; 5(10):2079-2092. PubMed ID: 28744527 [TBL] [Abstract][Full Text] [Related]
9. Migration of marrow stromal cells in response to sustained release of stromal-derived factor-1alpha from poly(lactide ethylene oxide fumarate) hydrogels. He X; Ma J; Jabbari E Int J Pharm; 2010 May; 390(2):107-16. PubMed ID: 20219655 [TBL] [Abstract][Full Text] [Related]
10. Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF. Pike DB; Cai S; Pomraning KR; Firpo MA; Fisher RJ; Shu XZ; Prestwich GD; Peattie RA Biomaterials; 2006 Oct; 27(30):5242-51. PubMed ID: 16806456 [TBL] [Abstract][Full Text] [Related]
11. Dual independent delivery of pro-angiogenic growth factors from starPEG-heparin hydrogels. Zieris A; Chwalek K; Prokoph S; Levental KR; Welzel PB; Freudenberg U; Werner C J Control Release; 2011 Nov; 156(1):28-36. PubMed ID: 21763368 [TBL] [Abstract][Full Text] [Related]
12. Avidity-controlled delivery of angiogenic peptides from injectable molecular-recognition hydrogels. Mulyasasmita W; Cai L; Hori Y; Heilshorn SC Tissue Eng Part A; 2014 Aug; 20(15-16):2102-14. PubMed ID: 24490588 [TBL] [Abstract][Full Text] [Related]
13. Integrin-specific hydrogels functionalized with VEGF for vascularization and bone regeneration of critical-size bone defects. García JR; Clark AY; García AJ J Biomed Mater Res A; 2016 Apr; 104(4):889-900. PubMed ID: 26662727 [TBL] [Abstract][Full Text] [Related]
15. Enhanced angiogenic efficacy through controlled and sustained delivery of FGF-2 and G-CSF from fibrin hydrogels containing ionic-albumin microspheres. Layman H; Li X; Nagar E; Vial X; Pham SM; Andreopoulos FM J Biomater Sci Polym Ed; 2012; 23(1-4):185-206. PubMed ID: 21192837 [TBL] [Abstract][Full Text] [Related]
16. Injectable and tunable hyaluronic acid hydrogels releasing chemotactic and angiogenic growth factors for endodontic regeneration. Silva CR; Babo PS; Gulino M; Costa L; Oliveira JM; Silva-Correia J; Domingues RMA; Reis RL; Gomes ME Acta Biomater; 2018 Sep; 77():155-171. PubMed ID: 30031163 [TBL] [Abstract][Full Text] [Related]
17. Photo-crosslinkable and biodegradable Pluronic/heparin hydrogels for local and sustained delivery of angiogenic growth factor. Yoon JJ; Chung HJ; Park TG J Biomed Mater Res A; 2007 Dec; 83(3):597-605. PubMed ID: 17503533 [TBL] [Abstract][Full Text] [Related]
18. Pro-angiogenic near infrared-responsive hydrogels for deliberate transgene expression. Martín-Saavedra F; Escudero-Duch C; Prieto M; Sánchez-Casanova S; López D; Arruebo M; Voellmy R; Santamaría J; Vilaboa N Acta Biomater; 2018 Sep; 78():123-136. PubMed ID: 30098440 [TBL] [Abstract][Full Text] [Related]
19. pH-responsive and enzymatically-responsive hydrogel microparticles for the oral delivery of therapeutic proteins: Effects of protein size, crosslinking density, and hydrogel degradation on protein delivery. Koetting MC; Guido JF; Gupta M; Zhang A; Peppas NA J Control Release; 2016 Jan; 221():18-25. PubMed ID: 26616761 [TBL] [Abstract][Full Text] [Related]
20. Degradable poly(ethylene glycol) (PEG)-based hydrogels for spatiotemporal control of siRNA/nanoparticle delivery. Wang Y; Zhang S; Benoit DSW J Control Release; 2018 Oct; 287():58-66. PubMed ID: 30077736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]